EMEA (Europe, Middle East and Africa) Anti-Inflammatory Drugs (NSAIDs) Market Report 2017

December 2017 | 100 pages | ID: EEAC902AB42EN
QYResearch

Abstracts

In this report, the EMEA Anti-Inflammatory Drugs (NSAIDs) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Anti-Inflammatory Drugs (NSAIDs) for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-Inflammatory Drugs (NSAIDs) market competition by top manufacturers/players, with Anti-Inflammatory Drugs (NSAIDs) sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie
• Amgen
• AstraZeneca
• Eli Lily
• GlaxoSmithKline
• Roche
• Johnson & Johnson
• Merck
• Novartis
• Pfizer

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Anti-inflammatory Biologics
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hosptical
• Pharmacy
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Anti-Inflammatory Drugs (NSAIDs) Market Report 2017

1 ANTI-INFLAMMATORY DRUGS (NSAIDS) OVERVIEW

1.1 Product Overview and Scope of Anti-Inflammatory Drugs (NSAIDs)
1.2 Classification of Anti-Inflammatory Drugs (NSAIDs)
  1.2.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Anti-inflammatory Biologics
  1.2.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  1.2.5 Corticosteroids
  1.2.6 Others
1.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Market by Application/End Users
  1.3.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hosptical
  1.3.3 Pharmacy
  1.3.4 Other
1.4 EMEA Anti-Inflammatory Drugs (NSAIDs) Market by Region
  1.4.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Anti-Inflammatory Drugs (NSAIDs) (2012-2022)
  1.5.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2022)

2 EMEA ANTI-INFLAMMATORY DRUGS (NSAIDS) COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Competition by Players/Manufacturers
  2.1.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Sale Price by Players (2012-2017)
2.2 EMEA Anti-Inflammatory Drugs (NSAIDs) (Volume and Value) by Type/Product Category
  2.2.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Sale Price by Type (2012-2017)
2.3 EMEA Anti-Inflammatory Drugs (NSAIDs) (Volume) by Application
2.4 EMEA Anti-Inflammatory Drugs (NSAIDs) (Volume and Value) by Region
  2.4.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Price by Region (2012-2017)

3 EUROPE ANTI-INFLAMMATORY DRUGS (NSAIDS) (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
  3.1.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
3.2 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type
3.3 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Application
3.4 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume by Countries (2012-2017)
  3.4.2 Europe Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2012-2017)
  3.4.3 Germany Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  3.4.4 France Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  3.4.5 UK Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  3.4.6 Russia Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  3.4.7 Italy Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTI-INFLAMMATORY DRUGS (NSAIDS) (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
  4.1.1 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
4.2 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type
4.3 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Application
4.4 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  4.4.4 Israel Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  4.4.5 UAE Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  4.4.6 Iran Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)

5 AFRICA ANTI-INFLAMMATORY DRUGS (NSAIDS) (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Value (2012-2017)
  5.1.1 Africa Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
5.2 Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type
5.3 Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Application
5.4 Africa Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Anti-Inflammatory Drugs (NSAIDs) Sales Volume by Countries (2012-2017)
  5.4.2 Africa Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2012-2017)
  5.4.3 South Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate (2012-2017)

6 EMEA ANTI-INFLAMMATORY DRUGS (NSAIDS) MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AstraZeneca
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lily
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Novartis
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Pfizer
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANTI-INFLAMMATORY DRUGS (NSAIDS) MANUFACTURING COST ANALYSIS

7.1 Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Inflammatory Drugs (NSAIDs)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Inflammatory Drugs (NSAIDs) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET FORECAST (2017-2022)

11.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Price and Trend Forecast (2017-2022)
11.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Type (2017-2022)
11.7 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-Inflammatory Drugs (NSAIDs)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) by Type (2012-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-inflammatory Biologics Product Picture
Figure Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure Corticosteroids Product Picture
Figure Others Product Picture
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Anti-Inflammatory Drugs (NSAIDs) by Application in 2016
Figure Hosptical Examples
Table Key Downstream Customer in Hosptical
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Market Size (Million USD) by Region (2012-2022)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Share by Players (2012-2017)
Figure 2016 Anti-Inflammatory Drugs (NSAIDs) Sales Share by Players
Figure 2017 Anti-Inflammatory Drugs (NSAIDs) Sales Share by Players
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Players (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2012-2017)
Table 2016 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players
Table 2017 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Inflammatory Drugs (NSAIDs) by Type (2012-2017)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Inflammatory Drugs (NSAIDs) by Type in 2016
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-Inflammatory Drugs (NSAIDs) by Application (2012-2017)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application in 2016
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-Inflammatory Drugs (NSAIDs) by Region (2012-2017)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in 2016
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anti-Inflammatory Drugs (NSAIDs) by Region (2012-2017)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Regions in 2016
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2012-2017)
Table Europe Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Type (2012-2017)
Table Europe Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Market Share by Type in 2016
Table Europe Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Application (2012-2017)
Table Europe Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2016
Table Europe Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Countries (2012-2017)
Table Europe Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Countries in 2016
Table Europe Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2012-2017)
Table Europe Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2016
Figure Germany Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure France Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure UK Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Russia Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Italy Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Type (2012-2017)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2012-2017)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2012-2017)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Applications (2012-2017)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Market Share by Applications (2012-2017)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application in 2016
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) by Countries (2012-2017)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume Market Share by Countries in 2016
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Israel Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure UAE Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Iran Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Type (2012-2017)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type in 2016
Table Africa Anti-Inflammatory Drugs (NSAIDs) Sales (Units) by Application (2012-2017)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2012-2017)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Sales Volume (Units) by Countries (2012-2017)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Countries in 2016
Table Africa Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2012-2017)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2016
Figure South Africa Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Table AbbVie Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure AbbVie Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Amgen Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table Amgen Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Amgen Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure Amgen Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Eli Lily Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure Eli Lily Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Roche Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table Roche Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Roche Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Roche Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure Roche Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Merck Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table Merck Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Merck Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure Merck Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Novartis Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table Novartis Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Novartis Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure Novartis Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Pfizer Anti-Inflammatory Drugs (NSAIDs) Basic Information List
Table Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate (2012-2017)
Figure Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in EMEA (2012-2017)
Figure Pfizer Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Inflammatory Drugs (NSAIDs)
Figure Manufacturing Process Analysis of Anti-Inflammatory Drugs (NSAIDs)
Figure Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
Table Raw Materials Sources of Anti-Inflammatory Drugs (NSAIDs) Major Manufacturers in 2016
Table Major Buyers of Anti-Inflammatory Drugs (NSAIDs)
Table Distributors/Traders List
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anti-Inflammatory Drugs (NSAIDs) Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources